Metogest
Clinical data | |
---|---|
ATC code | None |
Identifiers | |
| |
CAS Number | 52279-58-0 |
PubChem (CID) | 9839398 |
ChemSpider | 8015116 |
UNII | BPY4IK3W14 |
Chemical and physical data | |
Formula | C20H30O2 |
Molar mass | 302.451 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Metogest (INN, USAN) (developmental code name SC-14207), also known as 16,16-dimethyl-19-nortestosterone, is a steroidal antiandrogen that was patented in 1975 and investigated as a treatment for acne but was never marketed.[1][2][3]
See also
References
- ↑ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 816–. ISBN 978-1-4757-2085-3.
- ↑ R.A. Hill; H.L.J. Makin; D.N. Kirk; G.M. Murphy (23 May 1991). Dictionary of Steroids. CRC Press. pp. 676–. ISBN 978-0-412-27060-4.
- ↑ J. Horsky; J. Presl (6 December 2012). Ovarian Function and its Disorders: Diagnosis and Therapy. Springer Science & Business Media. pp. 112–. ISBN 978-94-009-8195-9.
This article is issued from Wikipedia - version of the 10/22/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.